Clinical Trial: Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes

U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07387003) titled 'Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes' on Jan. 28.

Brief Summary: This study will be conducted to evaluate the efficacy and safety of GZR101-80 Injection in patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs or Basal/Premixed Insulin.

Study Start Date: March 20

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes (T2DM)

Intervention: DRUG: GZR101-80

Administered SC

DRUG: Insulin degludec/Insulin aspart or Insulin aspart30 (NovoRapid(R)30)

Administered SC

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Gan & Lee Pharmaceuticals.

Publ...